News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Ashish Manne: The Potential of Cell-Free DNA Methylation Sequencing in Pancreatic Ductal Adenocarcinoma
Ashish Manne/X
May 28, 2025, 10:09

Ashish Manne: The Potential of Cell-Free DNA Methylation Sequencing in Pancreatic Ductal Adenocarcinoma

Ashish Manne, GI Medical Oncologist and Associate Professor at Ohio State University Comprehensive Cancer Center, shared a post on LinkedIn:

“Excited to share that we’ll be presenting our latest work at ASCO25!
Our poster highlights the potential of cell-free DNA methylation sequencing to better understand and predict treatment response in pancreatic ductal adenocarcinoma (PDA).
This work reflects our continued focus on decoding the biology of PDA — because in this disease, Biology Is King.
Looking forward to connecting with colleagues and collaborators in Chicago!”

Ashish Manne announced his team’s upcoming presentation at ASCO 2025, focusing on the use of cfDNA methylation sequencing to improve treatment response prediction in pancreatic ductal adenocarcinoma.

Ashish Manne: The Potential of Cell-Free DNA Methylation Sequencing in Pancreatic Ductal Adenocarcinoma

More posts on Adenocarcinoma on OncoDaily.

Adenocarcinoma ASCO25 Ashish Manne cancer Cell-Free DNA Methylation Sequencing Chicago fight against cancer Global fight against cancer James Cancer Hospital Ohio State University Comprehensive Cancer Center OncoDaily Oncology pancreatic ductal adenocarcinoma
Special Coverage
Blog
Jul 9, 2025, 21:20
Herbert Loong: Sarcomas Are a Group of Rare Diseases Which Benefits From Awareness and Specialist Care
Opinion
Jul 9, 2025, 21:08
Paolo Tarantino Opens the 3rd Annual ADC Toxicity Summit
Insight
Jul 9, 2025, 21:02
Marianna Vitaloni: I'm Incredibly Grateful to the Patients Who Shared Their Stories With Us
Blog
Jul 9, 2025, 20:28
Jennifer Guida: I Had the Privilege to Lead Pioneering Work at the NCI Focused on Cancer Survivorship, Healthy Aging, and Resilience
Blog
Jul 9, 2025, 20:10
Every Person Living with NCDs Such as Cancer Has Access to the Treatment and Care They Need - UICC
Blog
Jul 9, 2025, 19:55
Erythropoietin Promotes an Immunosuppressive Tumor Microenvironment in Liver Cancer Models - NCI Division of Cancer Biology
Blog
Jul 9, 2025, 19:35
UF Health Cancer Center Welcomed Nearly 150 Middle and High School Science Teachers From Across the Southeast
Blog
Jul 9, 2025, 19:16
SIOP Provides Scholarships to Nurses Who Have Insufficient Resources to Participate and to Travel to Our Congress
Blog
Jul 9, 2025, 18:36
2nd Synergies Forum Marks Milestone for Pediatric and Young Adult Cancer Advocacy in Europe - ELLOK
Insight
Jul 9, 2025, 18:16
Akhil Kapoor: We Acknowledge and Appreciate the Trial’s Bold and Innovative Approach in Challenging Established Treatment Paradigms
Blog
Jul 9, 2025, 17:59
Afreen Shariff: Ready to Take Cancer Care to New Heights?
Blog
Jul 9, 2025, 17:48
Adrian Pogacian: New Developments in Scanxiety Live Webinar